Misoprostol and Ranitidine in the Prevention of NSAID-Induced Ulcers: A Prospective, Double-Blind, Multicenter Study

Raskin, Jeffrey B.; White, Richard H.; Jaszewski, Richard; Korsten, Mark A.; Schubert, Timothy T.; Fort, John G.
February 1996
American Journal of Gastroenterology;Feb1996, Vol. 91 Issue 2, p223
Academic Journal
Objective: To compare ranitidine to misoprostol with respect to the prevention of gastric and duodenal ulcers in patients on chronic NSAID therapy. Methods: A multi-center, 8-wk, randomized, double-blind study. Eligible patients were on chronic NSAID therapy and were experiencing NSAID-related upper gastrointestinal (UGI) pain without UGI endoscopic evidence of gastric or duodenal ulcers. Patients enrolled in the study were randomized to either misoprostol 200 µg q.i.d. or ranitidine 150 mg b.i.d.. Follow-up UGI endoscopy was performed after 4 and 8 wk of treatment. Therapeutic failure was considered the development of a gastric or duodenal ulcer ≥ 0.3 cm in diameter with perceptible depth. Results: Gastric ulcers were found in only 1/180 (0.56%) patient on misoprostol and in 11/194 (5.67%) patients on ranitidine, a difference that was statistically significant (p < 0.01). Duodenal ulcer rates were similar for the ranitidine (2/185 or 1.08%) and misoprostol (2/ 181 or 1.10%) groups. Conclusion: Misoprostol is significantly more effective than ranitidine in the prevention of NSAID-induced gastric ulcers. Ranitidine was as effective as misoprostol for the prevention of NSAID-induced duodenal ulcers. Misoprostol should be used for prophylaxis against both gastric and duodenal ulceration in patients on chronic NSAID therapy.


Related Articles

  • Omeprazole, the Victor! Young, R. L.; Thompson, Jon S. // American Journal of Gastroenterology;Aug1998, Vol. 93 Issue 8, p1200 

    Discusses research being done on the comparison between ranitidine and omeprazole, and misoprostol and omeprazole for non-steroidal anti-inflammatory drug (NSAID)-associated ulcer treatment. Investigation on the efficacy of omeprazole and ranitidine in patients with gastroduodenal ulcers and...

  • Risk of Uncomplicated Peptic Ulcer among Users of Aspirin and Nonaspirin Nonsteroidal Antiinflammatory Drugs. Luis Alberto García Rodríguez; Sonia Hernández-Díaz // American Journal of Epidemiology;Jan2004, Vol. 159 Issue 1, p23 

    The association between nonsteroidal antiinflammatory drugs (NSAIDs) and upper gastrointestinal complications is well documented. However, epidemiologic data on the risk of clinically symptomatic but uncomplicated peptic ulcer are quite limited. The authors studied the association between...

  • Cimetidine in the Treatment of Gastric Ulcer Induced by Steroidal and Nonsteroidal Anti-inflammatory Agents. LoIudice, Thomas A.; Saleem, Tariq; Lang, Jean Anne // American Journal of Gastroenterology;Feb1981, Vol. 75 Issue 2, p104 

    The study of a group of patients with gastric ulcers induced by anti-inflammatory agents, was undertaken in an attempt to ascertain the effectiveness of cimetidine (Tagamet®) when compared with intensified doses of antacids in their treatment. Seventy patients with medication-induced benign...

  • Herbal Remedy: An Alternate Therapy of Nonsteroidal Anti-Inflammatory Drug Induced Gastric Ulcer Healing. Chatterjee, Ananya; Bandyopadhyay, Sandip K. // Ulcers;2014, p1 

    Nonsteroidal anti-inflammatory drugs (NSAIDs) are one of the most commonly used therapeutic drug groups used worldwide for curing an array of health problems like pain, inflammation, cardiovascular complications, and many other diseases, but they may cause different side effects including...

  • New treatment guidelines target NSAID-induced ulcers. Portyansky, Elena // Drug Topics;11/2/98, Vol. 142 Issue 21, p24 

    Discusses the guidelines for the management of ulcers caused by nonsteroidal anti-inflammatory drugs (NSAID), published in the November 1998 issue of the `American Journal of Gastroenterology.' Use of misoprostol as a preventive strategy; Warning against the erroneous practice of using H2...

  • ranitidine.  // Royal Society of Medicine: Medicines;2002, p468 

    This article presents information on anti-ulcer drug ranitidine. It is used in the treatment of benign peptic ulcers. Nonsteroidal anti-inflammatory drug-induced ulceration, and as prophylaxis to relieve heartburn in cases of reflux esophagitis, Zollinger-Ellison syndrome and a variety of...

  • Famotidine. Friedman, G. // American Journal of Gastroenterology;Jun1987, Vol. 82 Issue 6, p504 

    Provides several facts about famotidine, a potent H2 receptor antagonist. Difference of famotidine from ranitidine in terms of potency; Efficacy of famotidine in treating duodenal ulcers according to several studies; Side effects.

  • Rantec.  // Royal Society of Medicine: Medicines;2002, p469 

    This article presents information on Rantec, a proprietary, prescription-only preparation of the anti-ulcer drug ranitidine. It can be used to treat benign peptic ulcers, gastro-esophageal reflux, dyspepsia and associated conditions. It is available as tablets.

  • NSAID-related ulcers: Two studies compare three preventive agents.  // Geriatrics;Jun98, Vol. 53 Issue 6, p107 

    Presents summaries of two articles found in the March 12, 1998 issue of the `New England Journal of Medicine,' which looked at the effectiveness of omeprazole, ranitidine and misoprostol in the treatment of nonsteroidal anti-inflammatory drug-related ulcers. Details on the studies conducted;...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics